Standout Papers

Glioma targeted therapy: insight into future of molecular approaches 2020 2026 2022 2024436
  1. Glioma targeted therapy: insight into future of molecular approaches (2022)
    Keyang Yang, Zhijing Wu et al. Molecular Cancer
  2. Immunosenescence: molecular mechanisms and diseases (2023)
    Zaoqu Liu, Yuqing Ren et al. Signal Transduction and Targeted Therapy
  3. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer (2021)
    Hao Zhang, Ziyu Dai et al. Journal of Experimental & Clinical Cancer Research
  4. PARP inhibitor resistance: the underlying mechanisms and clinical implications (2020)
    He Li, Zhaoyi Liu et al. Molecular Cancer
  5. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials (2023)
    Hao Zhang, Zhe Chen et al. Molecular Cancer
  6. Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts (2022)
    Yuchen Wang, Hao Zhang et al. Journal of Hematology & Oncology
  7. Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database (2023)
    Chaozheng Zhou, Shengkun Peng et al. EClinicalMedicine
  8. CTLs heterogeneity and plasticity: implications for cancer immunotherapy (2024)
    Anqi Lin, Aimin Jiang et al. Molecular Cancer
  9. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets (2025)
    Ruixuan Wang, Peng Luo et al. Signal Transduction and Targeted Therapy
  10. Multi-stage mechanisms of tumor metastasis and therapeutic strategies (2024)
    Zaoqu Liu, Jingqi Chen et al. Signal Transduction and Targeted Therapy
  11. Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways (2025)
    Bowei Liu, Zhigang Peng et al. Molecular Cancer

Immediate Impact

4 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study
2025 Standout
Pancreatic cancer
2025 Standout
1 intermediate paper

Works of Quan Cheng being referenced

Immunosenescence: molecular mechanisms and diseases
2023 Standout
PARP inhibitor resistance: the underlying mechanisms and clinical implications
2020 Standout

Author Peers

Author Last Decade Papers Cites
Quan Cheng 2565 1805 1388 1567 252 6.2k
Nan Zhang 2482 1805 1448 1301 268 5.8k
Jingqin Luo 2549 3116 1316 2191 191 7.7k
Qingyu Wu 2276 983 835 1005 224 7.6k
Arkadiusz Z. Dudek 3233 2710 1827 978 212 7.1k
Eugene Goldwasser 3598 938 753 937 179 9.6k
Aly Karsan 5515 1526 864 2092 200 9.3k
Raffaele Calogero 5401 1178 752 1097 178 8.1k
Jianxiang Wang 3693 2076 403 1092 400 7.5k
Jaime Rodriguez‐Canales 2640 2782 1211 1228 160 6.6k
Shuli Li 2055 1165 717 1142 232 6.7k

All Works

Loading papers...

Rankless by CCL
2026